ProCE Banner Series

Reaching the “Fourth 90”: Can Long-Acting Agents Play a Role?

Join us in Brisbane or virtually for this live symposium, where a panel of expert faculty and people living with HIV from around the globe discusses the concept of the "fourth 90," opportunities for long-acting ART to improve quality of life in people living with HIV, and challenges and opportunities with the implementation of long-acting ART.

Please note: You must be registered to attend IAS 2023 to attend this symposium. To register for the conference: https://www.iasociety.org/conferences/ias2023/registration

Not an official event of IAS. Not sponsored, endorsed, or accredited by IAS.

  ACPE
  | AMA
  | ANCC
Who Should Attend

This program is intended for physicians, pharmacists, registered nurses and other healthcare professionals who provide care for people living with HIV.

All Events

Reaching the "Fourth 90": Can Long-Acting Agents Play a Role?

Past Events

July

25

2023

7:30 AM - 8:30 AM Australian Eastern Standard Time (AEST)

In-personVirtual

Brisbane Convention & Exhibition Centre, Glenelg St South Brisbane QLD 4101, Australia

Faculty

ProCE Banner Faculty
Iskandar Azwa, MBChB, MRCP

Associate Professor
Infectious Diseases
Faculty of Medicine
University of Malaya
Kuala Lumpur, Malaysia

ProCE Banner Faculty
Nikos Dedes

Positive Voice
Athens, Greece

ProCE Banner Faculty
Beng Eu, MBBS

Doctor
Prahran Market Clinic 
Melbourne, Victoria, Australia 

ProCE Banner Faculty
Bernadette Sharp

Advocate

ProCE Banner Faculty
Jeff Taylor

Executive Director 
HIV+Aging Research Project
Palm Springs, California

Topics

Welcome and Introductions

What is the "Fourth 90"?

  • Discuss why patient-reported outcomes are an important measure of ART success

Can LA-ART Improve Quality of Life?

  • Acceptability of injectable ART
  • Psychological impact
  • Greater confidentiality

Implementing LA-ART: Challenges and Opportunities

  • Access to clinic visits and medications
  • Increased frequency of clinic visits
  • Increased interactions with the healthcare team
  • Evolution of long-acting ART and future directions

Question and Answer Session

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact meetings@clinicaloptions.com prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve learners' knowledge and competence in implementing antiretroviral treatment strategies that may improve the health-related quality of life of people living with HIV.

Target Audience
This program is intended for physicians, pharmacists, registered nurses and other healthcare professionals who provide care for people living with HIV.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Apply a thorough understanding of the "fourth 90" when assessing the health and wellbeing of people living with HIV
  • Identify people living with HIV who are appropriate candidates for LA-ART and may benefit not only in terms of virologic and immunologic response, but also in terms of the potential impact on HRQoL
  • Integrate practical strategies to administer and monitor long-acting ART correctly, and support people living with HIV to maximize their overall HRQoL and wellbeing

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-23-149-L02-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.